From: Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
 | HR | 95% CI | P | |
---|---|---|---|---|
Age | 1.03 | 1.01 | 1.04 | 0.001 |
male | 1.34 | 1.01 | 1.79 | 0.043 |
smoker | 1.39 | 1.03 | 1.87 | 0.032 |
BMI | 0.95 | 0.92 | 0.98 | 0.002 |
FVC % predicteda | 0.78 | 0.72 | 0.84 | < 0.001 |
DLco % predicteda | 0.56 | 0.5 | 0.63 | < 0.001 |
GORD treatment | 0.99 | 0.75 | 1.31 | NS |
GORD typical symptoms | 0.88 | 0.66 | 1.16 | NS |
GORD disease | 1.07 | 0.83 | 1.39 | NS |
FSSG score > 8 | 0.85 | 0.66 | 1.10 | NS |